Brainify.AI is an AI biomarker platform for the development of novel treatments for depression that increases the likelihood of new treatment approval and increases drug efficacy. We are members of J&J Labs and Merck DSS. Brainify.AI is backed by Merck GHI Fund, Northpond, and Kodori VC
| Website | http://brainify.ai |
| Employees | 12 (9 on RocketReach) |
| Founded | 2021 |
| Phone | +1 855-712-1818 |
| Industry | Mental Health Care |
| Keywords | Data Driven Healthcare, Machine Learning Healthcare, Drug Efficacy, Ai Healthcare, Mental Health Ai, Biomarker Discovery, Pharmaceutical Ai, Drug Development Ai, Ai Diagnostics, Precision Medicine Ai, Digital Therapeutics, Mental Health Technology, Clinical Trials, New Drug Discovery, Biotech Ai, Personalized Medicine |
| Competitors | Amazon, Microsoft, IBM, Salesforce, NVIDIA, OpenAI, DataRobot, C3 AI, H2O.ai, AI Community +37 more (view full list) |
Looking for a particular Brainify.AI employee's phone or email?
Mariam Khayretdinova is the Founder and CEO of Brainify.AI.
9 people are employed at Brainify.AI.
Brainify.AI is based in New York, New York.